Van Bever H P, Stevens W J
Department of Paediatrics, University of Antwerp, Belgium.
Clin Exp Allergy. 1989 Jul;19(4):399-404. doi: 10.1111/j.1365-2222.1989.tb02405.x.
In this study, we wanted to test the hypothesis that hyposensitization (HS) abrogates the late asthmatic reaction (LAR). We therefore selected 15 asthmatic children (subjects) sensitized to house dust mite (HDM), as proven by positive prick tests and/or specific IgE via the RAST. All children demonstrated a positive bronchial provocation test (BPT) to HDM; 14 showed a dual asthmatic reaction and one child showed an isolated LAR. All children were treated with anti-asthmatic drugs and received HS. They were rechallenged after 1 yr of HS while their anti-asthmatic medication was not changed, except for beta-agonists which were used only for relief of symptoms. Two BPTs, with a mean interval of 6.4 months, were also performed in eight asthmatic children (controls), who did not receive HS. In the controls, the same reaction pattern was observed during both BPTs. In the subjects, the LAR completely resolved in 5/15 after 1 yr of HS (P = 0.04). Furthermore, as a group, the subjects showed a less severe LAR after 1 yr of HS (expressed as mean fall of FEV1) (P less than 0.0001). The PD20 of the immediate asthmatic reaction (IAR) was the same as before HS was started, but the IAR was also less severe after 1 yr of HS (expressed as mean fall of FEV1) (P = 0.028). From these observations it is concluded that, in asthmatic children, HS may resolve and/or reduce the severity of the LAR. Although the PD20 of the IAR is not changed, the severity of the IAR is also reduced after 1 yr of HS.
在本研究中,我们想要检验低敏治疗(HS)可消除哮喘迟发反应(LAR)这一假设。因此,我们选择了15名对屋尘螨(HDM)过敏的哮喘儿童(研究对象),其皮内试验阳性和/或通过放射性变应原吸附试验检测到特异性IgE可证实这一点。所有儿童对HDM支气管激发试验(BPT)均呈阳性;14名儿童表现出双重哮喘反应,1名儿童表现出孤立的迟发反应。所有儿童均接受抗哮喘药物治疗并进行低敏治疗。在低敏治疗1年后,他们在抗哮喘药物不变的情况下再次接受激发试验,β受体激动剂仅用于缓解症状时除外。8名未接受低敏治疗的哮喘儿童(对照组)也进行了两次BPT,平均间隔6.4个月。在对照组中,两次BPT期间观察到相同的反应模式。在研究对象中,低敏治疗1年后,15名中有5名迟发反应完全消失(P = 0.04)。此外,作为一个整体,研究对象在低敏治疗1年后迟发反应较轻(以第一秒用力呼气容积(FEV1)平均下降表示)(P<0.0001)。速发哮喘反应(IAR)的PD20与开始低敏治疗前相同,但低敏治疗1年后IAR也较轻(以FEV1平均下降表示)(P = 0.028)。从这些观察结果得出结论,在哮喘儿童中,低敏治疗可能消除和/或降低迟发反应的严重程度。虽然IAR的PD20没有改变,但低敏治疗1年后IAR的严重程度也有所降低。